IMMU Financial Facts
Sales and marketing: 215.86KForeign currency transaction gain: 2.46K
See Full Income Statement
Total Assets: 40.61M
Other long-term assets: 30K
See Full Balance Sheet
Immunomedics (IMMU) Earnings
|
Expand Research on IMMU
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -44.0% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +2.9% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
8/5/20 | Q220 | N/A | -$0.34 | N/A | N/A | $14.53M | N/A | N/A | N/A | ||
5/6/20 | Q120 | -$0.44 | -$0.45 | +$0.01 | N/A | $2.36M | N/A | Details | |||
2/27/20 | Q419 | -$0.50 | -$0.46 | -$0.04 | $295K | $530K | N/A | Details | |||
10/30/19 | Q319 | -$0.49 | -$0.40 | -$0.09 | N/A | $400K | N/A | Details | |||
2/25/19 | Q219 | -$0.84 | -$0.34 | -$0.50 | N/A | $50K | N/A | Details | |||
11/7/18 | Q119 | -$0.34 | N/A | N/A | N/A | $1.86M | N/A | Details | |||
8/23/18 | Q418 | -$0.68 | -$0.22 | -$0.46 | $400K | $4.27M | N/A | Details | |||
5/9/18 | Q318 | -$0.21 | -$0.15 | -$0.06 | $500M | $1.3M | = | Details |